Total Payments
$10,718
2024 Payments
$1,261
Companies
40
Transactions
408
Medicare Patients
733
Medicare Billing
$95,630
Payment Breakdown by Category
Food & Beverage$10,633 (99.2%)
Education$49.34 (0.5%)
Other$35.76 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,633 | 400 | 99.2% |
| Education | $49.34 | 6 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35.76 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,587 | 91 | $0 (2024) |
| AbbVie Inc. | $1,035 | 31 | $0 (2023) |
| GlaxoSmithKline, LLC. | $962.19 | 33 | $0 (2024) |
| Lilly USA, LLC | $902.43 | 31 | $0 (2024) |
| Amarin Pharma Inc. | $662.55 | 29 | $0 (2021) |
| Allergan, Inc. | $547.33 | 25 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $521.80 | 11 | $0 (2023) |
| Amgen Inc. | $449.73 | 16 | $0 (2023) |
| Merck Sharp & Dohme LLC | $407.85 | 25 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $271.66 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,261 | 38 | AstraZeneca Pharmaceuticals LP ($517.77) |
| 2023 | $1,809 | 49 | GlaxoSmithKline, LLC. ($441.61) |
| 2022 | $1,445 | 49 | AstraZeneca Pharmaceuticals LP ($411.99) |
| 2021 | $1,140 | 51 | AstraZeneca Pharmaceuticals LP ($265.03) |
| 2020 | $1,127 | 54 | Allergan, Inc. ($340.84) |
| 2019 | $1,336 | 52 | AstraZeneca Pharmaceuticals LP ($351.44) |
| 2018 | $1,600 | 63 | Amarin Pharma Inc. ($319.58) |
| 2017 | $1,001 | 52 | AstraZeneca Pharmaceuticals LP ($190.56) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Diabetes Care | ||||||
| 09/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: VACCINES | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 07/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: PAIN | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: VACCINE | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Gastroenterology | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: VACCINE | ||||||
| 04/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $106.56 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 219 | 344 | $46,214 | $28,544 |
| 2022 | 4 | 175 | 273 | $33,460 | $22,046 |
| 2021 | 6 | 204 | 302 | $41,250 | $28,639 |
| 2020 | 4 | 135 | 236 | $27,017 | $16,401 |
Total Patients
733
Total Services
1,155
Medicare Billing
$95,630
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 180 | $20,745 | $13,034 | 62.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $7,995 | $5,614 | 70.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 53 | $8,224 | $4,931 | 60.0% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 25 | 25 | $7,500 | $4,621 | 61.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 25 | $1,250 | $278.52 | 22.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 20 | $500.00 | $64.79 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 162 | $17,010 | $11,089 | 65.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $8,970 | $6,484 | 72.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 45 | $6,480 | $4,258 | 65.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 20 | $1,000 | $215.12 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 167 | $17,080 | $11,203 | 65.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 46 | 46 | $8,970 | $6,745 | 75.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 50 minutes | Office | 2021 | 25 | 25 | $7,500 | $5,911 | 78.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 30 | $4,320 | $2,929 | 67.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,280 | $1,626 | 71.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 20 | 22 | $1,100 | $225.42 | 20.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 162 | $15,390 | $9,342 | 60.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 43 | 43 | $8,385 | $5,519 | 65.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 18 | $2,592 | $1,372 | 52.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 13 | $650.00 | $168.16 | 25.9% |
About Dr. Natalia Bilan, MD
Dr. Natalia Bilan, MD is a Family Medicine healthcare provider based in Rancho Santa Margarita, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376644377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Natalia Bilan, MD has received a total of $10,718 in payments from pharmaceutical and medical device companies, with $1,261 received in 2024. These payments were reported across 408 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($10,633).
As a Medicare-enrolled provider, Bilan has provided services to 733 Medicare beneficiaries, totaling 1,155 services with total Medicare billing of $95,630. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Rancho Santa Margarita, CA
- Active Since 09/25/2006
- Last Updated 11/27/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376644377
Products in Payments
- FARXIGA (Drug) $1,431
- VRAYLAR (Drug) $1,098
- Vascepa (Drug) $662.55
- SYMBICORT (Drug) $492.18
- XARELTO (Drug) $438.85
- MOUNJARO (Drug) $339.38
- UBRELVY (Drug) $298.27
- TRELEGY ELLIPTA (Drug) $294.09
- NURTEC ODT (Drug) $293.99
- TRULICITY (Drug) $281.56
- AIRSUPRA (Drug) $272.82
- XIFAXAN (Drug) $271.66
- BREZTRI (Drug) $268.65
- Aimovig (Biological) $181.06
- Livalo (Drug) $167.94
- QUVIVIQ (Drug) $157.94
- EMGALITY (Drug) $152.14
- AREXVY (Drug) $145.98
- JANUVIA (Drug) $145.11
- Otezla (Drug) $142.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rancho Santa Margarita
Dr. Peter Desilva, Md, MD
Family Medicine — Payments: $7,712
Family Medicine $7,712
Alexa Desilva, Pa-C, PA-C
Family Medicine — Payments: $4,787
Family Medicine $4,787
Dr. Faranak Ghazi, Md, MD
Family Medicine — Payments: $753.10
Family Medicine $753.10
Mr. Kenneth Kazenelson, M.d, M.D
Family Medicine — Payments: $543.26
Family Medicine $543.26
Dr. Mark Cianciola, Md, MD
Family Medicine — Payments: $478.73
Family Medicine $478.73
Dr. Mark Adlard, M.d, M.D
Family Medicine — Payments: $292.19
Family Medicine $292.19